Company Research Report: Creo Medical

Company Overview

• Name: Creo Medical Group

• Mission: To transform patient lives by delivering pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world.

• Founded: June 2003

• Founder: Professor Chris Hancock

• CEO: Craig Gulliford (appointed in 2012)

• Key People: Chris Hancock (Founder), Craig Gulliford (CEO)

• Headquarters: Chepstow, UK

• Number of Employees: 281 (as of June 30, 2023)

• Revenue: £15.7 million

• Known For: Pioneering Advanced Energy technology in the field of surgical endoscopy, empowering minimally invasive procedures with their Kamaptive Technology.

Products

Overview

Creo Medical specializes in Advanced Energy devices driven by Kamaptive Technology, offering solutions for therapeutic endoscopy across various specialities including Gastroenterology, Urology, Pulmonology, and Surgery.

Key Products

1. Speedboat™ Inject:

• Description: The first advanced energy multi-modal instrument designed for flexible endoscopy delivering both advanced bipolar RF and microwave energy.

• Key Features:

• Delivers precise cutting and coagulation.

• Enables minimally invasive procedures.

• Proven safety and efficiency in reducing theatre time and hospital stays.

2. CROMA Advanced Energy Platform:

• Description: An energy platform powered by Kamaptive Technology delivering both advanced bipolar RF for cutting and super high-frequency microwave energy for coagulation.

• Key Features:

• Adaptable technology for flexibility in procedures.

• Supports a suite of multi-modal devices.

3. MicroBlate™ Fine:

• Description: A microwave needle ablation device, similar in size to a standard biopsy needle for soft tissue ablation.

• Key Features:

• Suitable for precise tissue coagulation.

• Less than 1mm in diameter.

4. MicroBlate™ Flex:

• Description: A flexible microwave ablation device for soft tissue where flexibility is crucial.

• Key Features:

• Adapted for challenging anatomical areas.

5. Speedboat™ UltraSlim:

• Description: Slimmest advanced energy device designed for flexible endoscopy, delivering both RF and microwave energy.

• Key Features:

• Enhanced precision for tight anatomical spaces.

Recent Developments

Technological Advancements

• Kamaptive Technology: Continues to expand with partnerships and technology licensing, facilitating its integration into different surgical tools and enhancing its application in robotic and laparoscopic surgery.

• Speedboat Technology Impact: Studies at East Kent University Hospital have shown significant cost savings and operational efficiency benefits.

New Products and Features

• Launch of Speedboat™ UltraSlim: Marking its early commercial launch in Europe.

• CROMA Platform Enhancements: Ongoing optimization to expand compatibility with robotic-assisted surgical platforms.

Strategic Partnerships

• Kamaptive Licensing Programme:

• Intuitive Surgical: Multi-year collaboration optimizing Creo products for compatibility with Intuitive’s robotic technology.

• CMR Surgical: Licensing agreement for the integration of Creo’s technology with the Versius® robotic surgery system.

Industry Impact

• Wales’ Reduced Screening Age: Adoption of Creo’s technology, specifically Speedboat, for managing the expected rise in cancer screenings and treatment efficacy.

• Clinical Education: Launch of the Pioneer Clinical Education Programme, providing training and support to healthcare professionals worldwide in advanced therapeutic endoscopy practices.

Conclusion

Creo Medical is a leader in the development of innovative medical devices for therapeutic endoscopy, with its advanced energy solutions significantly improving procedural outcomes and patient care efficiency. The company continues to expand its reach through strategic partnerships, product advancements, and educational initiatives.